TFS - About the company
TFS is an acquired company based in Lund (Sweden), founded in 1996 by Daniel Spasic. It operates as an A global mid-service CRO providing clinical research services. The company has 367 active competitors, including 13 funded and 111 that have exited. Its top competitors include companies like Novotech, Emmes and Syneos Health.
Company Details
TFS is a clinical Contract Research Organization providing clinical research services to pharmaceutical, healthcare, life sciences, biotech and medical device companies. Their services include Scientific advice, Product development consulting, Proof of concept, PK/PD Modelling and simulation, Protocol design, Regulatory affairs strategy, Preparation and submission of CTA/ITA, IND, PMA/510(k), Interaction with regulatory agencies world-wide, Orphan Drug Designations and Pediatric Investigational Plans.
- Website
- tfscro.com
- Email ID
- *****@tfscro.com
Legal entities associated with TFS
TFS is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Net Profit | Employee Count |
---|---|---|---|---|
Dec 31, 1999 | - | 595 | 176 |
TFS's acquisition details
TFS got acquired by Ratos on Sep 07, 2015. It was facilitated by William Blair.
Click here to take a look at TFS's acquisition in detail
TFS's funding and investors
TFS has not raised any funding rounds yet.
TFS's founders and board of directors
Founder? Claim ProfileView details of TFS's Founder profiles and Board Members
TFS's employee count trend
TFS has 103 employees as of Dec 22. The total employee count is 58.0% more than what it was in Dec 21. Here is TFS's employee count trend over the years:Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
TFS's Competitors and alternates
Top competitors of TFS include Novotech, Emmes and Syneos Health. Here is the list of Top 10 competitors of TFS, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
---|---|---|---|---|---|
1st | Full-service CRO focused exclusively on Asia Pacific | $255M | 73/100 | ||
2nd | Emmes 1977, Rockville (United States), Acquired | Provider of outsourced CRO services | - | 69/100 | |
3rd | Syneos Health 1984, Raleigh (United States), Public | Provider of CRO clinical development | - | 67/100 | |
4th | Veristat 1994, Southborough (United States), Acquired | CRO for clinical trials and regulatory submission | - | 66/100 | |
5th | ClinChoice 1995, Fort Washington (United States), Series E | CRO focused on data management, regulatory affairs and consulting services | $212M | 63/100 | |
6th | A global mid-service CRO providing clinical research services | - | - | 62/100 | |
7th | Medelis WCCT Global 1998, Cypress (United States), Acquired | Full-service CRO with expertise in influenza research and oncology | $17M | 59/100 | |
8th | Parexel 1983, Waltham (United States), Acquired | Global full-service CRO | - | 59/100 | |
9th | hVIVO 1998, London (United Kingdom), Public | Provider of cell based assays, field trial, and molecular services for biopharma sector | - | 59/100 | |
10th | Celgene 1986, Summit (United States), Acquired | Developer of therapies for treating cancer and inflammatory diseases | $45M | 59/100 |
Looking for more details on TFS's competitors? Click here to see the top ones
TFS's Investments and acquisitions
TFS has made no investments or acquisitions yet.
Reports related to TFS
Here is the latest report on TFS's sector:
News related to TFS
Media has covered TFS for a total of 10 events in the last 1 year, 6 of them have been about people movement and 4 about partnerships.
•
TFS HealthScience Expands Collaboration with Oncomatryx for Phase Ib Trial of OMTX705 for Pancreatic CancerPR Newswire•May 06, 2025•TFS, Oncomatryx
•
TFS expands its collaboration with Oncomatryx for the OMTX705 IB phase test for pancreatic cancerPR Newswire•May 06, 2025•TFS, Oncomatryx
•
TFS HealthScience Expands Collaboration with Oncomatryx for Pancreatic Cancer TrialPR Newswire•May 06, 2025•TFS, Oncomatryx
•
•
•
•
TFS HealthScience appoints Katarina Ageborg as Chair, Markus Granlund as Acting CEO.PR Newswire•Feb 25, 2025•TFS, Astrazeneca
•
•
•
TFS HealthScience appoints Katarina Ageborg as Chairman, Markus Granlund as Acting CEO.PR Newswire•Feb 24, 2025•TFS
Are you a Founder ?
FAQ's about TFS
Explore our recently published companies
- Pluteo - Unfunded company
- Pneuhaefliger - Unfunded company
- Search Marketing Experts - Los Angeles based, 2005 founded, Unfunded company
- Georgia Bridal Show - Roswell based, 1990 founded, Unfunded company
- Battery Group - Unfunded company
- Taim Hotel - 2019 founded, Unfunded company